Both in Pharmaceuticals
Citius Oncology vs Clene
Over the past year CTOR returned −66.8% and CLNN returned −68.0%; their daily moves had a correlation of 0.07.
CTOR −66.8% CLNN −68.0%Growth of $1, one year, split-adjusted
| Metric | CTOR | CLNN |
|---|---|---|
| Price | $0.5540 | $3.83 |
| Market cap | $58.6M | $54.4M |
| Today | +4.63% | −1.79% |
| 1 month | −43.5% | −4.7% |
| 6 months | −41.4% | −37.6% |
| Year to date | −44.6% | −34.8% |
| 1 year | −68.3% | −58.1% |
| Revenue growth (YoY) | — | +233.3% |
| Gross margin | 67.1% | 60.0% |
| Net margin | −597.4% | −14915.6% |
| P/E (TTM) | — | — |
| Price / sales | 8.2× | 276.3× |
| Net cash | $10.2M | -$9.1M |
| Dividend yield | — | — |
| Volatility (60d) | 96.7% | 81.7% |
| Short % of float | 0.8% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).